Biomet Inc. on Thursday accepted a sweetened takeover bid of $11.4 billion from a group of private equity firms after a influential shareholder advisory firm urged the orthopedic device maker’s shareholders to reject a previous $10.9 billion offer.
*For more on this story,
read the full Reuters
article.
